Dry skin, itching, and fiery eczema can be caused by allergens, stress, or an overactive immune response.Steroid creams ...
7d
MedPage Today on MSNInitiating Systemic Therapy for PsoriasisUntil about 20 years ago, systemic treatment options for moderate/severe psoriasis were limited and nonspecific. To get an ...
A diet of fruits and vegetables, whole grains, low-fat dairy foods and lean meats, low in salt and sugar, is associated with ...
Celltrion has launched Steqeyma (ustekinumab-stba), its biosimilar of Stelara (ustekinumab), at list price at an 85% discount ...
Results from multiple Phase III trials of Icotrokinra in moderate-to-severe plaque psoriasis and a Phase IIb trial in ...
Adults and adolescents treated with icotrokinra experienced improvements in their moderate to severe plaque psoriasis, ...
Karishmma Chawla, a Functional Medicine & Lifestyle Educator, explains, “Food is the most intimate part of our body. It ...
6d
MedPage Today on MSNRapid, Substantial Psoriasis Improvement With Oral IL-23 InhibitorTwo-thirds of patients with moderate or severe plaque psoriasis had complete or nearly complete clearance at 4 months with an ...
Five-year data from Phase III trials demonstrated that 67.7% of patients moderate-to-severe plaque psoriasis treated with UCB ...
Tildrakizumab showed early and sustained effectiveness and quality of life (QOL) improvements in patients with moderate to ...
Late-breaking Oral Presentation Efficacy and Safety of a Highly Selective Oral TYK2 Inhibitor, ICP-488, in Patients with Moderate-to-Severe Plaque Psoriasis: A Phase II, Randomized, Double-blinded, ...
Two posters presented at the 2025 American Academy of Dermatology Annual Meeting highlighted the importance of improving ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results